<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-vaccines-08-00036">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Escriou</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Callendret</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Lorin</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Combredet</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Marianneau</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Fevrier</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Tangy</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein</article-title>
  <source>Virology</source>
  <year>2014</year>
  <volume>452</volume>
  <fpage>32</fpage>
  <lpage>41</lpage>
  <pub-id pub-id-type="doi">10.1016/j.virol.2014.01.002</pub-id>
  <pub-id pub-id-type="pmid">24606680</pub-id>
 </element-citation>
</ref>
